We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NYXH market cap is 267.68M. The company's latest EPS is EUR -1.5077 and P/E is -5.72.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 976k | 1.82M | 1.22M | 771k | 1.27M |
Operating Income | -10.99M | -10.84M | -12.21M | -13.31M | -14.98M |
Net Income | -7.61M | -10.89M | -11.91M | -13.12M | -17.06M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 0 | 69k | 852k | 3.08M | 4.35M |
Operating Income | -7.72M | -11.23M | -26.24M | -32.5M | -45.1M |
Net Income | -8.45M | -12.25M | -27.62M | -31.23M | -43.21M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 134.6M | 124.16M | 113.02M | 148.23M | 142.76M |
Total Liabilities | 26.06M | 26.14M | 25.82M | 28.09M | 38.06M |
Total Equity | 108.54M | 98.02M | 87.2M | 120.14M | 104.71M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 15.2M | 114.08M | 170.83M | 146.07M | 124.16M |
Total Liabilities | 12.83M | 16.89M | 22.21M | 25.75M | 26.14M |
Total Equity | 2.36M | 97.19M | 148.62M | 120.32M | 98.02M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -33.1M | -44.78M | -12.28M | -23.59M | -37.03M |
Investing | 11.25M | 32.01M | 12.64M | -15.56M | -9.75M |
Financing | 17.58M | 16.86M | -253k | 44.98M | 54.06M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -5.96M | -7.02M | -25.34M | -28.76M | -44.78M |
Investing | -5.8M | -10.69M | -11.82M | -89.95M | 32.01M |
Financing | 733k | 104.18M | 76.47M | -983k | 16.86M |
Market Cap | 267.68M |
Price to Earnings Ratio | -5.72 |
Price to Sales Ratio | 56.82 |
Price to Cash Ratio | 11.43 |
Price to Book Ratio | 2.52 |
Dividend Yield | - |
Shares Outstanding | 28.66M |
Average Volume (1 week) | 61.51k |
Average Volume (1 Month) | 54.28k |
52 Week Change | 96.22% |
52 Week High | 20.00 |
52 Week Low | 4.00 |
Spread (Intraday) | 0.61 (6.56%) |
Company Name | Nyxoah SA |
Address |
12 rue edouard belin mont-saint-guibert, walloon brabant 1435 |
Website | https://www.nyxoah.com |
Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions